Alpha‐2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery
D Duncan, A Sankar, WS Beattie… - Cochrane Database …, 2018 - cochranelibrary.com
Background The surgical stress response plays an important role on the pathogenesis of
perioperative cardiac complications. Alpha‐2 adrenergic agonists attenuate this response …
perioperative cardiac complications. Alpha‐2 adrenergic agonists attenuate this response …
Alpha‐2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery
DN Wijeysundera, JS Bender… - Cochrane database of …, 2009 - cochranelibrary.com
Background The surgical stress response plays an important role on the pathogenesis of
perioperative cardiac complications. Alpha‐2 adrenergic agonists attenuate this response …
perioperative cardiac complications. Alpha‐2 adrenergic agonists attenuate this response …
Beta‐adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery
K Mostafaie, R Bedenis… - Cochrane Database of …, 2015 - cochranelibrary.com
Background People undergoing major vascular surgery have an increased risk of
postoperative cardiac complications. Beta‐adrenergic blockers represent an important and …
postoperative cardiac complications. Beta‐adrenergic blockers represent an important and …
Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications:: A meta-analysis
DN Wijeysundera, JS Naik, WS Beattie - The American journal of medicine, 2003 - Elsevier
PURPOSE: To investigate the effects of α2-adrenergic agonists on perioperative mortality
and cardiovascular complications in adults undergoing surgery. METHODS: MEDLINE …
and cardiovascular complications in adults undergoing surgery. METHODS: MEDLINE …
Alpha2-adrenergic agonists and their role in the prevention of perioperative adverse cardiac events.
SA Chalikonda - AANA journal, 2009 - search.ebscohost.com
Alpha2-adrenergic agonists have been shown to reduce the incidence of perioperative
myocardial morbidity and mortality, The purpose of this review article is to summarize the …
myocardial morbidity and mortality, The purpose of this review article is to summarize the …
Perioperative adverse events attributed to α2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysis
M Demiri, T Antunes, D Fletcher, V Martinez - British Journal of Anaesthesia, 2019 - Elsevier
Background Several systematic reviews have reported the benefits of perioperative α2-
adrenoceptor agonist use for various conditions, but safety evidence is poorly documented …
adrenoceptor agonist use for various conditions, but safety evidence is poorly documented …
Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing non‐cardiac surgery
H Blessberger, SR Lewis, MW Pritchard… - Cochrane Database …, 1996 - cochranelibrary.com
Abstract Background Randomized controlled trials (RCTs) have yielded conflicting results
regarding the ability of beta‐blockers to influence perioperative cardiovascular morbidity …
regarding the ability of beta‐blockers to influence perioperative cardiovascular morbidity …
Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery
H Blessberger, SR Lewis, MW Pritchard… - Cochrane Database …, 1996 - cochranelibrary.com
Abstract Background Randomized controlled trials (RCTs) have yielded conflicting results
regarding the ability of beta‐blockers to influence perioperative cardiovascular morbidity …
regarding the ability of beta‐blockers to influence perioperative cardiovascular morbidity …
Improving cardiac outcomes after noncardiac surgery
J Butterworth, CD Furberg - Anesthesia & Analgesia, 2003 - journals.lww.com
There has long been interest in reducing cardio-vascular complications after surgical
operations (specifically, myocardial ischemia, myocardial infarction [MI], or cardiac death). In …
operations (specifically, myocardial ischemia, myocardial infarction [MI], or cardiac death). In …
Are the recommendations to use perioperative β-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?
Furthermore, the relative risk reductions of 75%–80% in this meta-analysis are inconsistent
with the results of RCTs that showed benefits of cardiovascular therapies, which have …
with the results of RCTs that showed benefits of cardiovascular therapies, which have …